New studies are shedding light on how omega-3 fatty acids—measured by the Omega-3 Index—influence asthma control, medication use, and long-term outcomes.
What Is Asthma and Why Omega-3s Matter
The National Heart, Lung, and Blood Institute (NHLBI) defines asthma as a chronic condition where airway inflammation and narrowing lead to wheezing, chest tightness, shortness of breath, and coughing. Triggers and severity vary, but effective management typically includes an asthma action plan: monitoring, avoiding triggers, and using medications like inhaled corticosteroids (ICS).
Because omega-3 fatty acids (EPA and DHA) have established anti-inflammatory properties, researchers are exploring their role as an adjunct therapy in asthma care.
The Study: Omega-3 Index and Asthma Control
A recent study in Nutrients compared the Omega-3 Index in adults with and without asthma:
-
Participants: 255 with asthma, 137 without.
-
Assessments: Blood samples (Omega-3 Index) + lung function (Juniper Asthma Control Questionnaire).
Key Findings
-
Overall Omega-3 Index levels were similar in people with and without asthma.
-
Within asthma patients, those with a higher Omega-3 Index (≥8%) had:
-
Better asthma control scores.
-
Lower maintenance ICS doses.
-
-
A low Omega-3 Index was associated with poorer asthma control.
Conclusion: Achieving an Omega-3 Index of ≥8% may support better asthma management and reduce medication dependence.
Evidence in Children
-
2018 Study – Journal of Allergy and Clinical Immunology: In Practice
-
Children with higher omega-3 levels were less likely to develop asthma or recurrent wheeze by age 3.
-
The strongest benefit was seen in children with higher vitamin D levels, suggesting a synergistic effect.
-
-
2022 Study – American Journal of Respiratory and Critical Care Medicine
-
In 135 Baltimore children, higher dietary omega-3 intake was linked to fewer asthma symptoms triggered by indoor air pollution.
-
Diets high in omega-6s (soy, corn oil) worsened asthma symptoms.
-
Researchers emphasized that improving diet alongside air quality may reduce asthma disparities.
-
Mixed Evidence: When Omega-3s Don’t Help
Not all trials find benefits:
-
A 2021 study (Annals of the American Thoracic Society) tested 4 g/day fish oil (3.18 g EPA+DHA) in obese adolescents with uncontrolled asthma.
-
After 6 months, no improvements in asthma control, lung function, or exacerbations were observed.
-
Authors noted obesity-related inflammation might blunt the benefits of omega-3s, and higher doses or longer treatment could be required.
Practical Implications
-
For adults with asthma: Aiming for an Omega-3 Index ≥8% could improve control and reduce medication needs.
-
For children: Omega-3s may lower risk of asthma and wheeze, especially when combined with adequate vitamin D.
-
For families in polluted environments: Omega-3-rich diets may help buffer the effects of poor air quality.
-
For clinicians: Omega-3 Index testing offers an evidence-based tool to personalize dietary and supplement guidance.
Key Takeaways
-
Higher Omega-3 Index = better asthma control and reduced ICS use.
-
Benefits extend to children, particularly when omega-3s and vitamin D are both sufficient.
-
Not all groups respond equally—obesity may complicate effectiveness.
-
Dietary shifts toward omega-3-rich foods (salmon, sardines, herring) and away from omega-6-heavy oils may offer protective benefits.